Team mission

The Gene Editing Target Discovery team identifies, prioritizes, and de-risks editing targets that can translate into pipeline programs.

What we own

• Target nomination and rationale
• Cross-functional alignment with Regulatory and IP
• Decision documentation for target scope and constraints

Who we partner with

• Regulatory: guidance and constraints that impact filing and study design
• IP: patentability, prior art review, and scope implications
• Program leadership: portfolio tradeoffs and capital allocation

What “durable” means here

Decisions remain traceable, attributable, and visible over time - not just stored, but preserved with context.